Email this page: News Release
Pain Therapeutics Announces FDA Has Cleared an Investigational New Drug (IND) Application for PTI-125
To (email address):
Separate multiple addresses with commas. Maximum 200 characters.
Your email address:
These email addresses will be used to email the page on your behalf and will not be used by Pain Therapeutics for any marketing purposes.
Add a comment:
Link to page
Type in number:
This helps Pain Therapeutics prevent automated submissions.